Prognia
Drug Database
🇺🇸US · FDA ApprovedNone (Tentative Approval)NDA217070-001

ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE(ABACAVIR)

Manufacturer: AUROBINDO PHARMA USA

FDA Approval: 14/08/2023

Route: ORAL · TABLET

Active Ingredients

ABACAVIR 60MG; DOLUTEGRAVIR 5MG; LAMIVUDINE 30MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.